2m 2m 2m 2m 2m 2m 2m
CITIUS PHARMACTC (CTXR)
NASDAQ
$0.50+$0.01 (+3.00%)
Price as of Nov 12, 2026 8:52 AM EST- $13.2MMarket Cap
- -56.51%1-Year Change
- BiotechnologyIndustry
CITIUS PHARMACTC (CTXR)
$0.50+$0.01 (+3.00%)
CTXR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.48 | ||
Change | -$0.01 (-2.48%) | ||
Open | $0.50 | ||
High | $0.50 | ||
Low | $0.48 | ||
Previous Close | $0.49 | ||
Volume | 177,713 | ||
30-Day Average Volume | 279,137 | ||
1-Week Change | -12.78% | ||
1-Month Change | -3.76% | ||
1-Year Change | -56.51% | ||
3-Year Change | -97.50% | ||
5-Year Change | -98.94% | ||
Fundamentals | |||
Shares Outstanding | 27.5M | ||
Total Assets | $142.3M | ||
Market Cap | $13.2M | ||
Enterprise Value | $302.6M | ||
Period: QTR TTM FY | |||
Revenue | $1.5M | ||
Net Income | -$11.9M | ||
Free Cash Flow | -$8.7M | ||
EBIT | -$11.8M | ||
EBITDA | -$10.1M | ||
Net Working Capital | -$8.3M | ||
EPS | -$0.34 | ||
Enterprise Value/EBITDA | -30 | ||
Enterprise Value/Revenue | 203 | ||
P/B | 0 | ||
P/E | -1 | ||
PEG | -0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 11/26/2024 | ||